| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.041 | 0.1 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |